LANTHANUM CARBONATE

Post-LOE

lanthanum carbonate

Teva

ANDAORALTABLET, CHEWABLE

Approved

Jan 2022

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

5/8 — Partial

LANTHANUM CARBONATE (lanthanum carbonate) by Teva is unabsorbed. Approved for serum phosphate in patients with end-stage renal disease (esrd). First approved in 2022.

Drug data last refreshed 20h ago

$0.0BPart D

Mechanism of Action

unabsorbed. Both serum phosphate and calcium phosphate product are reduced as a consequence of the reduced dietary phosphate absorption.

Indications (1)

serum phosphate in patients with end-stage renal disease (ESRD)

Clinical Trials (18)

NCT06218290Phase 2Completed

A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis

Started Dec 2023

106 enrolled

Chronic Kidney Disease Requiring Chronic Dialysis

NCT02952040Phase 1Completed

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

Started Nov 2016

18 enrolled

Healthy Subjects

NCT01696279Phase 2Completed

A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis

Started Feb 2013

63 enrolled

Chronic Kidney DiseaseHyperphosphatemia

NCT01581996N/ACompleted

Fosrenol and Phosphorus Balance - Lanthanum Carbonate

Started Mar 2012

9 enrolled

Chronic Kidney FailureEnd-stage Renal DiseaseDisorders Associated With Peritoneal Dialysis

NCT01578200Phase 3Completed

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study

Started Dec 2011

2,309 enrolled

HemodialysisHyperphosphatemia

Worked on LANTHANUM CARBONATE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.